Department of Physics, Chemistry and Pharmacy, University of Southern Denmark, Campusvej 55, 5230, Odense M, Denmark.
NNF Center for Basic Metabolic Research, Section for Metabolic Receptology, Faculty of Health and Medical Sciences, University of Copenhagen, Blegdamsvej 3, 2200, Copenhagen, Denmark.
Sci Rep. 2018 Jul 3;8(1):10010. doi: 10.1038/s41598-018-28263-7.
The succinate receptor 1 (SUCNR1) is a receptor for the metabolite succinate, which functions as a metabolic stress signal in the liver, kidney, adipose tissue and the retina. However, potent non-metabolite tool compounds are needed to reveal the physiological role and pharmacological potential of SUCNR1. Recently, we published the discovery of a computationally receptor-structure derived non-metabolite SUCNR1 agonist series with high target selectivity. We here report our structure-activity exploration and optimisation that has resulted in the development of agonists with nanomolar potency and excellent solubility and stability properties in a number of in vitro assays. Ligand-guided receptor models with high discriminative power between binding of active and inactive compounds were developed for design of novel chemotypes.
琥珀酸受体 1(SUCNR1)是代谢物琥珀酸的受体,在肝脏、肾脏、脂肪组织和视网膜中作为代谢应激信号发挥作用。然而,需要有效的非代谢物工具化合物来揭示 SUCNR1 的生理作用和药理学潜力。最近,我们发表了一项计算受体结构衍生的非代谢物 SUCNR1 激动剂系列的发现,该系列具有高靶标选择性。我们在此报告我们的结构活性探索和优化,这导致了具有纳摩尔效力的激动剂的开发,并在许多体外测定中具有优异的溶解度和稳定性。具有高区分活性和非活性化合物结合能力的配体引导受体模型被开发出来,用于设计新型化学型。